Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 22 | 19 | 18 | 18 | 18 |
| Accounts receivable | -17 | -33 | 536 | -508 | -8 |
| Other Working Capital | -119 | 93 | -153 | -480 | 580 |
| Other Operating Activity | -1,381 | -543 | -161 | 165 | -1,412 |
| Operating Cash Flow | $-1,494 | $-463 | $240 | $-805 | $-822 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -24 | -24 | -22 | -22 | -22 |
| Common Stock Issued | 48,629 | 0 | 0 | 0 | 900 |
| Other Financing Activity | 3,436 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $52,041 | $-24 | $-22 | $-22 | $878 |
| Exchange Rate Effect | 1,630 | 17 | 40 | -2 | -42 |
| Beginning Cash Position | 5,720 | 6,190 | 5,932 | 6,762 | 6,748 |
| End Cash Position | 57,897 | 5,720 | 6,190 | 5,932 | 6,762 |
| Net Cash Flow | $50,547 | $-487 | $218 | $-827 | $56 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,494 | -463 | 240 | -805 | -822 |
| Free Cash Flow | -1,494 | -463 | 240 | -805 | -822 |